Stem cell repair of infarcted myocardium: An overview for clinicians

Circulation

Volumn 108, Issue 9, 2003, Pages 1139-1145

  Forrester, James S ^a   Price, Matthew J ^b   Makkar, Raj R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Heart failure; Myocardial infarction; Remodeling; Stem cells

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; BONE MARROW CELL; CELL CULTURE; ENDOTHELIUM CELL; HEART INFARCTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

BONE MARROW CELLS; CELL FUSION; CELL MOVEMENT; CLINICAL TRIALS; HUMANS; INJECTIONS; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 0042316981     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000085305.82019.65     Document Type: Review

References (59)

1. Graf T. Differentiation plasticity of hematopoietic cells. Blood. 2002;99: 3089-3101.
2. Malouf NN, Coleman WB, Girsham JW, et al. Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol. 2001;158:1929-1935.
3. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature. 2001;414:92-97.
4. Jackson KA, Majka SM, Wulf GG, et al. Stem cells: a minireview. J Cell Biochem. 2002;(suppl 38):1-6.
5. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res. 2002;91:1092-1102.
6. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344: 1750-1757.
7. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)ACl33(+) endothelial precursor cells. Circ Res. 2001;88:167-174.
8. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776-2779.
9. Etzion S, Battler A, Barbash IM, et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol, 2001;33: 1321-1330.
10. Jain M, DerSimonian H, Brenner DA, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 2001;103:1920-1927.
11. Rajnoch C, Chachques JC, Berrebi A, et al. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg. 2001;121:871-878.
12. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929-933.
13. Li RK, Welsel RD, Mickle DA, et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg. 2000;119:62-68.
14. Penn MS, Francis GS, Ellis SG, et al. Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis. 2002;45: 21-32.
15. Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98: 2512-2523.
16. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol. 2002;34:241-249.
17. Guan K, Furst DO, Wobus AM. Modulation of sarcomere organization during embryonic stem cell-derived cardiomyocyte differentiation. Eur J Cell Biol. 1999;78:813-823.
18. Yoon Y-A, Murayama T, Tkebuchawa T, et al. Clonally expanded bone marrow derived stem cells differentiate into multiple lineages in vitro and can attenuate myocardial dysfunction post myocardial infarction. Circulation. 2002;106(suppl II):11-51.
19. Lewis E, Qu X, Nakao M, et al. Cardiac differentiation markers do not support the ability of bone marrow cells to undergo in vitro transdifferentiation. Circulation. 2001;104(suppl II):II-2829.
20. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001;37:1726-1732.
21. Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci. 2001;938: 221-229.
22. Wang JS, Shum-Tim D, Chedrawy E, et al. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg. 2001;122:699-705.
23. Min JY, Yang Y, Converson KL, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol. 2002;92:288-296.
24. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 2002;123: 1132-1140.
25. Torrente Y, Camirand G, Pisati F, et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. Cell Biol. 2003;162:511-520.
26. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-981.
27. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625-637.
28. + cells to CXC, CC, and CX3C chemokines: implications for cell migration and activation. J Hematother Stem Cell Res. 2001;10:643-655.
29. Kocher AA, Schuster MD, Szaboles MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
30. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732-738.
31. Orlic D, Kajstura J, Chimenti S. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98:10344-10349.
32. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002; 297:2256-2259.
33. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545.
34. Ying Q-L, Nichols J, Evans E, et al. Changing potency by spontaneous fusion. Nature. 2002;416:545-548.
35. Liu Y, Rao MS. Transdifferentiation: factor artifact. J Cell Biochem. 2003;88:29-40.
36. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6: 1229-1234.
37. Rodney L, Rietze Rl, Valcanis H, et al. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature. 2001;412:736-739.
38. Garot J, Unterseeh T, Teiger E, et al. Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J Am Coll Cardiol. 2003;41: 1841-1846.
39. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919-1925.
40. Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337-346.
41. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
42. Devine SM, Bartholomew AM, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol. 2001;29:244-255.
43. Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75:389-397.
44. Bensinger WI, Clift RA, Anasetti C, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells. 1996;14:90-105.
45. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915-922.
46. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002;106:804-808.
47. Barron HV, Cannon CP, Murphy SA, et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000;102:2329-2334.
48. Forrester JS, Price M, Makkar R. Mending the broken heart. Clin Cardiol. 2003. In press.
49. Tomoda H, Aoki N. Bone marrow stimulation and left ventricular function in acute myocardial infarction. Clin Cardiol. 2003. In press.
50. Gutierrez-Delgado F, Bensinger W. Safety of granulocyte colony-stimulating factor in normal donors. Curr Opin Hematol. 2001;8:155-160.
51. Joos K, Herzog R, Einsele H, et al. Characterization and functional analysis of granulocyte concentrates collected from donors after repeated G-CSF stimulation. Transfusion. 2002;425:603-611.
52. Zhang YM, Hartzell C, Narlow M, et al. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation. 2002;106:1294-1299.
53. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-435.
54. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet. 2001;357:279-280.
55. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361:45-46.
56. Hamano K, Nishida M, Hirata K. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J. 2001;65: 845-847.
57. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106: 3009-3017.
58. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologus intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-1918.
59. Fuchs S, Weisz G, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility and safety study. Circulation 2002;106 (suppl II):II-655-II-656.